PetMed Express, Inc. stock trades under the ticker PETS & has shown recent bullishness that traders & investors should research further into.
PETS stock closed at $16.09/share on 4/4/2023.
PetMed Express, Inc. PETS Stock’s Technical Performance Broken Down
PETS Stock Analysis: $16.09
10 Day Moving Average: $16.28
50 Day Moving Average: $18.55
200 Day Moving Average: $19.18
RSI: 39.25
MACD: -0.648
Yesterday, PETS stock completed a bullish MACD crossover, but lost -2.84% on the day’s session.
Their RSI is approaching oversold at 39 & recent trading volumes have been about average compared to the year prior, as their price has slid throughout March 2023.
PETS stock has support at the $15.09 & $12.79/share price levels, with resistance at the $16.28 (10 day moving average), $16.60 & $16.96/share price levels.
PetMed Express, Inc. PETS Stock As A Long-Term Investment
Long-term oriented investors will like PETS stock’s 29.84 P/E (ttm), but may find their 2.64 P/B (mrq) to be a bit too rich.
They recently reported -3% Quarterly Revenue Growth Y-o-Y, which may warrant a closer review.
Investors will like their balance sheet, which contains $102.43M of Total Cash (mrq) & no Total Debt (mrq).
PETS stock pays a 7.25% dividend yield, which appears to be unsustainable in the long-run & will require more research, as their payout ratio is 214.29%.
82.38% of PETS stock’s outstanding share float is owned by institutional investors.
PetMed Express, Inc. PETS Stock As A Short-Term Trade Using Options
Traders with shorter time horizons can trade options to profit from price movements in PETS stock, while hedging their portfolios from volatility.
I am looking at the contracts with the 5/19 expiration date.
The $12.50 & $15 call options are in-the-money, listed in order of highest to lowest open interest level.
The $17.50, $30 & $20 puts are also all in-the-money, with the former being more liquid than the latter strikes.
Tying It All Together
PETS stock has many interesting attributes that traders & investors will find appealing.
Investors will like their balance sheet & hefty dividend yield, but may want to research deeper into its longevity potential.
Traders will like their recent technical performance, but may wish their options were more liquid.
Overall, it is worth taking a closer look into PETS stock to see how it fits into your portfolio strategy.
*** I DO NOT OWN SHARES OR OPTIONS CONTRACT POSITIONS IN PETS STOCK AT THE TIME OF PUBLISHING THIS ARTICLE ***